G W Albers

Summary

Affiliation: Stanford University
Country: USA

Publications

  1. ncbi Dose escalation study of the NMDA glycine-site antagonist licostinel in acute ischemic stroke
    G W Albers
    Stanford Stroke Center, Palo Alto, CA, USA
    Stroke 30:508-13. 1999
  2. ncbi Expanding the window for thrombolytic therapy in acute stroke. The potential role of acute MRI for patient selection
    G W Albers
    Stanford Stroke Center, Stanford University Medical Center, Palo Alto, CA, USA
    Stroke 30:2230-7. 1999
  3. ncbi Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study
    G W Albers
    Stanford Stroke Center, Stanford University Medical Center, Palo Alto, Calif 94304 1705, USA
    JAMA 283:1145-50. 2000
  4. ncbi Choice of endpoints in antiplatelet trials: which outcomes are most relevant to stroke patients?
    G W Albers
    Stanford Stroke Center, Department of Neurology and Neurological Sciences, Stanford University Medical Center, Palo Alto, CA 94304, USA
    Neurology 54:1022-8. 2000
  5. ncbi Yield of diffusion-weighted MRI for detection of potentially relevant findings in stroke patients
    G W Albers
    Stanford Stroke Center, Palo Alto, CA 94304, USA
    Neurology 54:1562-7. 2000
  6. ncbi Evaluation of early reperfusion and i.v. tPA therapy using diffusion- and perfusion-weighted MRI
    M P Marks
    Stanford Stroke Center, Stanford University Medical Center, CA 94305 5105, USA
    Neurology 52:1792-8. 1999
  7. ncbi Relationship between severity of MR perfusion deficit and DWI lesion evolution
    V N Thijs
    Stanford Stroke Center, Department of Neurology and Neurological Sciences, Stanford University Medical Center, Palo Alto, CA, USA
    Neurology 57:1205-11. 2001
  8. ncbi Perfusion MRI (Tmax and MTT) correlation with xenon CT cerebral blood flow in stroke patients
    J M Olivot
    Department of Neurology and Neurological Sciences and the Stanford Stroke Center, Stanford University Medical Center, 701 Welch Rd, Suite 325, Palo Alto, CA 94304, USA
    Neurology 72:1140-5. 2009
  9. ncbi Is early ischemic lesion volume on diffusion-weighted imaging an independent predictor of stroke outcome? A multivariable analysis
    V N Thijs
    Stanford Stroke Center, Department of Neurology and Neurological Sciences, Stanford University Medical Center, Palo Alto, CA 94304 0117, USA
    Stroke 31:2597-602. 2000
  10. ncbi Antithrombotic management of atrial fibrillation for stroke prevention in older people
    D C Tong
    Department of Neurology and Neurological Sciences, Stanford Stroke Center, Stanford University Medical Center, Stanford, California, USA
    Clin Geriatr Med 15:645-62. 1999

Collaborators

Detail Information

Publications22

  1. ncbi Dose escalation study of the NMDA glycine-site antagonist licostinel in acute ischemic stroke
    G W Albers
    Stanford Stroke Center, Palo Alto, CA, USA
    Stroke 30:508-13. 1999
    ..The purpose of this study was to assess the safety, tolerability, and pharmacokinetics of licostinel in patients with acute stroke...
  2. ncbi Expanding the window for thrombolytic therapy in acute stroke. The potential role of acute MRI for patient selection
    G W Albers
    Stanford Stroke Center, Stanford University Medical Center, Palo Alto, CA, USA
    Stroke 30:2230-7. 1999
    ....
  3. ncbi Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study
    G W Albers
    Stanford Stroke Center, Stanford University Medical Center, Palo Alto, Calif 94304 1705, USA
    JAMA 283:1145-50. 2000
    ..Tissue-type plasminogen activator (tPA) is the only therapy for acute ischemic stroke approved by the Food and Drug Administration...
  4. ncbi Choice of endpoints in antiplatelet trials: which outcomes are most relevant to stroke patients?
    G W Albers
    Stanford Stroke Center, Department of Neurology and Neurological Sciences, Stanford University Medical Center, Palo Alto, CA 94304, USA
    Neurology 54:1022-8. 2000
    ..The benefit of antiplatelet therapies for patients with recent cerebrovascular events is determined most accurately if stroke alone is chosen as the primary endpoint...
  5. ncbi Yield of diffusion-weighted MRI for detection of potentially relevant findings in stroke patients
    G W Albers
    Stanford Stroke Center, Palo Alto, CA 94304, USA
    Neurology 54:1562-7. 2000
    ..To determine whether diffusion-weighted imaging (DWI) could identify potentially clinically relevant findings in patients presenting more than 6 hours after stroke onset when compared with conventional MRI...
  6. ncbi Evaluation of early reperfusion and i.v. tPA therapy using diffusion- and perfusion-weighted MRI
    M P Marks
    Stanford Stroke Center, Stanford University Medical Center, CA 94305 5105, USA
    Neurology 52:1792-8. 1999
    ..To characterize the effects of recombinant tissue plasminogen activator (rt-PA) therapy and early reperfusion on diffusion-weighted (DWI) and perfusion-weighted imaging (PWI) changes observed following acute ischemic injury...
  7. ncbi Relationship between severity of MR perfusion deficit and DWI lesion evolution
    V N Thijs
    Stanford Stroke Center, Department of Neurology and Neurological Sciences, Stanford University Medical Center, Palo Alto, CA, USA
    Neurology 57:1205-11. 2001
    ....
  8. ncbi Perfusion MRI (Tmax and MTT) correlation with xenon CT cerebral blood flow in stroke patients
    J M Olivot
    Department of Neurology and Neurological Sciences and the Stanford Stroke Center, Stanford University Medical Center, 701 Welch Rd, Suite 325, Palo Alto, CA 94304, USA
    Neurology 72:1140-5. 2009
    ..The Improved PWI Methodology in Acute Clinical Stroke Study compares PWI findings with Xe-CT CBF values in patients experiencing symptomatic severe cerebral hypoperfusion...
  9. ncbi Is early ischemic lesion volume on diffusion-weighted imaging an independent predictor of stroke outcome? A multivariable analysis
    V N Thijs
    Stanford Stroke Center, Department of Neurology and Neurological Sciences, Stanford University Medical Center, Palo Alto, CA 94304 0117, USA
    Stroke 31:2597-602. 2000
    ..We investigated whether the volume of early ischemic brain lesions assessed with diffusion-weighted imaging (DWI) was an independent predictor of functional outcome...
  10. ncbi Antithrombotic management of atrial fibrillation for stroke prevention in older people
    D C Tong
    Department of Neurology and Neurological Sciences, Stanford Stroke Center, Stanford University Medical Center, Stanford, California, USA
    Clin Geriatr Med 15:645-62. 1999
    ..In patients who have contraindications to anticoagulation, aspirin is recommended...
  11. ncbi Evolution of apparent diffusion coefficient, diffusion-weighted, and T2-weighted signal intensity of acute stroke
    M G Lansberg
    Stanford Stroke Center, Stanford University Medical Center, Palo Alto, CA 94304, USA
    AJNR Am J Neuroradiol 22:637-44. 2001
    ..Application of an inversion recovery pulse results in lower, potentially more accurate, absolute ADC values...
  12. ncbi Evolution of cerebral infarct volume assessed by diffusion-weighted magnetic resonance imaging
    M G Lansberg
    Stanford Stroke Center, Palo Alto, CA 94304-1705, USA
    Arch Neurol 58:613-7. 2001
    ..These data in conjunction with data regarding the evolution of lesion volume during the first 24 hours after symptom onset may be useful in the design of pilot studies of therapies for acute stroke...
  13. ncbi Yield of combined perfusion and diffusion MR imaging in hemispheric TIA
    M Mlynash
    Department of Neurology and Neurological Sciences, Stanford Stroke Center, 701 Welch Road, Suite B325, Palo Alto, CA 94304, USA
    Neurology 72:1127-33. 2009
    ..Diffusion-weighted MRI (DWI) demonstrates acute ischemic lesions in approximately 30% of TIA patients; the yield of perfusion-weighted MRI (PWI) is unclear...
  14. ncbi Clinical importance of microbleeds in patients receiving IV thrombolysis
    W Kakuda
    Stanford Stroke Center, Stanford University Medical Center, Palo Alto, CA, USA
    Neurology 65:1175-8. 2005
    ..Cerebral microbleeds (MBs) detected on gradient echo (GRE) imaging may be a risk factor for hemorrhagic complications in patients with stroke treated with IV tissue plasminogen activator (tPA)...
  15. ncbi Outcome of angioplasty for atherosclerotic intracranial stenosis
    M P Marks
    Department of Radiology, Stanford Stroke Center, Stanford University Medical Center, California, 94305 5105, USA
    Stroke 30:1065-9. 1999
    ..We sought to assess the long-term outcome and efficacy of percutaneous transluminal angioplasty in the treatment of symptomatic intracranial atherosclerotic stenoses...
  16. ncbi Symptomatic intracranial atherosclerosis: outcome of patients who fail antithrombotic therapy
    V N Thijs
    Stanford Stroke Center, Department of Neurology and Neurological Sciences, Stanford University Medical Center, Palo Alto, CA 94304 0117, USA
    Neurology 55:490-7. 2000
    ..To determine the prognosis of patients with symptomatic intracranial atherosclerosis who fail antithrombotic therapy...
  17. ncbi Hyperperfusion syndrome with hemorrhage after angioplasty for middle cerebral artery stenosis
    A Y Liu
    Department of Radiology, Stanford Stroke Center, Stanford University School of Medicine, Stanford, CA, USA
    AJNR Am J Neuroradiol 22:1597-601. 2001
    ..To our knowledge, this is the first report of hyperperfusion syndrome after intracranial angioplasty of a distal MCA branch...
  18. ncbi Aptiganel hydrochloride in acute ischemic stroke: a randomized controlled trial
    G W Albers
    Stanford Stroke Center, 701 Welch Rd, Bldg B, Suite 325, Palo Alto, CA 94304, USA
    JAMA 286:2673-82. 2001
    ..The larger proportion of patients with favorable outcomes and lower mortality rate in the placebo group suggest that glutamate blockade with aptiganel may have detrimental effects in an undifferentiated population of stroke patients...
  19. ncbi MRI characteristics of cerebral air embolism from a venous source
    A Finley Caulfield
    Department of Neurology and Neurological Sciences, Stroke Center, Stanford University Medical Center, Palo Alto, CA, USA
    Neurology 66:945-6. 2006
  20. ncbi Diffusion and perfusion magnetic resonance imaging for the evaluation of acute stroke: potential use in guiding thrombolytic therapy
    D C Tong
    Department of Neurology, Stanford University Medical Center, California, USA
    Curr Opin Neurol 13:45-50. 2000
    ..The evidence supporting these uses is reviewed, and the future role of diffusion and perfusion weighted imaging in acute stroke management is discussed...
  21. ncbi Advances in intravenous thrombolytic therapy for treatment of acute stroke
    G W Albers
    Stanford Stroke Center, Palo Alto, California 94304, USA
    Neurology 57:S77-81. 2001
    ..Additional research is required to clarify the optimal use of these diagnostic techniques and their cost-effectiveness...
  22. ncbi Antithrombotic therapy for prevention and treatment of ischemic stroke
    G W Albers
    Neurology and Neurological Sciences, Stanford University Medical Center, Palo Alto, California, USA
    J Thromb Thrombolysis 12:19-22. 2001
    ..Efforts to prevent and treat ischemic stroke are complicated by the variety of etiologies underlying it and the selection of antithrombotic or thrombolytic therapy appropriate to the particular etiology...